Arete Wealth Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,262
Closed -$207K 678
2025
Q4
$207K Buy
4,262
+9
+0.2% +$446 0.01% 716
2025
Q3
$201K Sell
4,253
-36
-0.8% -$1.74K 0.01% 729
2025
Q2
$207K Sell
4,289
-132
-3% -$6.74K 0.01% 684
2025
Q1
$245K Sell
4,421
-232
-5% -$12.6K 0.02% 608
2024
Q4
$225K Hold
4,653
0.02% 660
2024
Q3
$268K Sell
4,653
-305
-6% -$16.5K 0.02% 553
2024
Q2
$240K Buy
+4,958
New +$239K 0.02% 604
2024
Q1
Sell
-5,684
Closed -$283K 676
2023
Q4
$283K Buy
5,684
+68
+1% +$3.33K 0.02% 574
2023
Q3
$301K Buy
+5,616
New +$299K 0.05% 342

Other funds holding SNY

Arete Wealth Advisors's SNY Position: Q1 2026 in Review

Arete Wealth Advisors sold out of Sanofi (SNY) in Q1 2026, closing a stake of 4,262 shares — an estimated $207K sold.

Arete Wealth Advisors first reported a position in SNY in Q3 2023 and held it in 9 quarters. The position peaked at $301K in Q3 2023. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Arete Wealth Advisors reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • Arete Wealth Advisors sold 4,262 Sanofi shares in Q1 2026, an estimated $207K.
  • Arete Wealth Advisors first reported a position in Sanofi in Q3 2023 and held it in 9 quarters.
  • Arete Wealth Advisors's Sanofi position peaked at $301K in Q3 2023.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Arete Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.